Pulse Biosciences Stock Price on November 6, 2024
| PLSE Stock | USD 19.63 1.84 10.34% |
Below is the normalized historical share price chart for Pulse Biosciences extending back to May 18, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pulse Biosciences stands at 19.63, as last reported on the 4th of January, with the highest price reaching 19.78 and the lowest price hitting 18.07 during the day.
If you're considering investing in Pulse Stock, it is important to understand the factors that can impact its price. Pulse Biosciences appears to be moderately volatile, given 3 months investment horizon. Pulse Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.084, which implies the firm had a 0.084% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Pulse Biosciences, which you can use to evaluate the volatility of the company. Please evaluate Pulse Biosciences' Risk Adjusted Performance of 0.0695, semi deviation of 4.21, and Coefficient Of Variation of 1328.03 to confirm if our risk estimates are consistent with your expectations.
At present, Pulse Biosciences' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 8.9 M, whereas Common Stock Total Equity is forecasted to decline to about 17.6 K. . At present, Pulse Biosciences' Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.27, whereas Price To Operating Cash Flows Ratio is forecasted to decline to (16.82). Pulse Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of May 2016 | 200 Day MA 13.216 | 50 Day MA 17.3147 | Beta 1.752 |
Pulse |
Sharpe Ratio = 0.084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PLSE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.38 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.45 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Pulse Biosciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pulse Biosciences by adding it to a well-diversified portfolio.
Price Book 15.2604 | Enterprise Value Ebitda (1.81) | Price Sales 60.229 | Shares Float 17.2 M | Wall Street Target Price 5 |
Related Headline
Repro Med Headline on 6th of November 2024
Accuray Reports Q1 Loss, Tops Revenue Estimates by zacks.com
Accuray delivered earnings and revenue surprises of 0 percent and 3.51, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Pulse Biosciences Valuation on November 6, 2024
It is possible to determine the worth of Pulse Biosciences on a given historical date. On November 6, 2024 Pulse was worth 17.2 at the beginning of the trading date compared to the closed value of 18.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pulse Biosciences stock. Still, in general, we apply an absolute valuation method to find Pulse Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pulse Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pulse Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 15.23 | 16.60 | 15.13 | 16.47 | 120,398 | |
11/06/2024 | 17.20 | 18.22 | 16.89 | 18.05 | 205,818 |
| 18.11 | 18.42 | 17.60 | 17.98 | 143,508 |
| Backtest Pulse Biosciences | | | Pulse Biosciences History | | | Pulse Biosciences Valuation | Previous | Next |
Pulse Biosciences Trading Date Momentum on November 6, 2024
| On November 07 2024 Pulse Biosciences was traded for 17.98 at the closing time. The top price for the day was 18.42 and the lowest listed price was 17.60 . The trading volume for the day was 143.5 K. The trading history from November 7, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.39% . The trading delta at closing time against the current closing price is 8.42% . |
Pulse Biosciences Fundamentals Correlations and Trends
By evaluating Pulse Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pulse Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pulse financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pulse Biosciences Stock history
Pulse Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pulse is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pulse Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pulse Biosciences stock prices may prove useful in developing a viable investing in Pulse Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.2 M | 58 M | |
| Net Loss | -57.3 M | -54.4 M |
Pulse Biosciences Quarterly Net Working Capital |
|
Pulse Biosciences Stock Technical Analysis
Pulse Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pulse Biosciences Period Price Range
Low | January 4, 2025
| High |
0.00 | 0.00 |
Pulse Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pulse Biosciences January 4, 2025 Market Strength
Market strength indicators help investors to evaluate how Pulse Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pulse Biosciences shares will generate the highest return on investment. By undertsting and applying Pulse Biosciences stock market strength indicators, traders can identify Pulse Biosciences entry and exit signals to maximize returns
Pulse Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pulse Biosciences' price direction in advance. Along with the technical and fundamental analysis of Pulse Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pulse to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0695 | |||
| Jensen Alpha | 0.3658 | |||
| Total Risk Alpha | 0.304 | |||
| Sortino Ratio | 0.0839 | |||
| Treynor Ratio | 0.2682 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Pulse Stock analysis
When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |